Related Experiment Video
Updated: Jul 16, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Dose-response relationship of exercise interventions on sleep quality in patients with depression: a systematic
Ziqi Gao1, Sujie Mao1, Yaxin Wang1
1Graduate Department, Harbin Sport University, Harbin, HeilongJiang, China.
Background:
This meta-analysis aimed to systematically evaluate the effects of exercise interventions on sleep quality in patients with depression and to explore the dose-response relationships of key intervention parameters.
Methods:
A comprehensive search was conducted in PubMed, Web of Science, Embase, Scopus, and the Cochrane Library to identify randomized controlled trials (RCTs). Standardized mean differences (SMDs) and 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup and sensitivity analyses were performed to examine potential dose-response relationships.
Results:
A total of 17 publications, including 19 randomized controlled trial comparisons and 1,457 participants, were included in this systematic review and meta-analysis. Pooled estimates indicated that exercise interventions significantly improved sleep quality [SMD = -0.37, 95% CI: -0.48 to -0.27]. Dose-response modeling suggested that exercise doses around 312.75 MET·min/week may be associated with greater improvements [Hedges' g = -0.51, 95% CI: -0.71 to -0.31]. Subgroup analyses suggested that mind-body exercise [SMD = -0.49, 95% CI: -0.63 to -0.35], durations of 9-12 weeks [SMD = -0.49, 95% CI: -0.74 to -0.24], fewer than two sessions per week [SMD = -0.47, 95% CI: -0.65 to -0.29], and sessions longer than 90 minutes [SMD = -0.42, 95% CI: -0.66 to -0.18] may be associated with favorable changes.
Conclusions:
Exercise interventions may improve sleep quality in individuals with depression, with potential benefits at low doses. These findings support individualized exercise prescriptions, but larger multicenter RCTs with long-term follow-up are needed to confirm the dose-response pattern and subgroup findings.
Systematic Review Registration:
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420251105568, identifier PROSPERO (CRD420251105568).
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
